van Tellingen, Olaf

Overcoming the blood–brain tumor barrier for effective glioblastoma treatment

van Tellingen, O., Yetkin-Arik, B., de Gooijer, M. C., Wesseling, P., Wurdinger, T., & de Vries, H. E. (2015) · Drug Resistance Updates

Barrier Structure and Function StudiesGlioma Diagnosis and Treatment

Cited by 1,035

Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2

de Gooijer, M. C., de Vries, N. A., Buckle, T., Buil, L. C. M., Beijnen, J. H., Boogerd, W., & van Tellingen, O. (2018) · Neoplasia

Drug Transport and Resistance MechanismsGlioma Diagnosis and Treatment

Cited by 136

Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity

Pogacar, Z., Johnson, J. L., Krenning, L., De Conti, G., Jochems, F., Lieftink, C., Velds, A., Wardak, L., Groot, K., Schepers, A., et al. (2022) · PLOS ONE

Telomeres, Telomerase, and SenescenceAdvanced Breast Cancer Therapies

Cited by 13

Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity

Pogacar, Z., Johnson, J. L., Krenning, L., De Conti, G., Lieftink, C., Velds, A., Wardak, L., Jochems, F., Groot, K., Schepers, A., et al. (2021) · PLoS ONE

Telomeres, Telomerase, and SenescenceAdvanced Breast Cancer Therapies

Cited by 13